THOMAS, Astrid Maria
 Distribuzione geografica
Continente #
NA - Nord America 12.557
EU - Europa 9.623
AS - Asia 7.890
SA - Sud America 1.022
Continente sconosciuto - Info sul continente non disponibili 677
AF - Africa 109
OC - Oceania 21
Totale 31.899
Nazione #
US - Stati Uniti d'America 12.307
SG - Singapore 2.998
CN - Cina 2.347
IT - Italia 1.873
RU - Federazione Russa 1.579
UA - Ucraina 1.374
IE - Irlanda 1.139
GB - Regno Unito 984
TR - Turchia 883
BR - Brasile 818
SE - Svezia 708
FR - Francia 692
VN - Vietnam 674
DE - Germania 562
IN - India 370
FI - Finlandia 321
BD - Bangladesh 177
CA - Canada 131
HK - Hong Kong 110
AR - Argentina 77
NL - Olanda 74
MX - Messico 68
JP - Giappone 63
PL - Polonia 58
ES - Italia 46
IQ - Iraq 39
AT - Austria 34
ZA - Sudafrica 34
CZ - Repubblica Ceca 33
EC - Ecuador 29
ID - Indonesia 26
CO - Colombia 25
LU - Lussemburgo 25
PK - Pakistan 25
BE - Belgio 23
IR - Iran 23
KR - Corea 23
CH - Svizzera 21
EU - Europa 20
MA - Marocco 19
CL - Cile 18
VE - Venezuela 18
UZ - Uzbekistan 17
EG - Egitto 14
PE - Perù 14
AU - Australia 13
IL - Israele 13
JM - Giamaica 13
LT - Lituania 13
AE - Emirati Arabi Uniti 12
MY - Malesia 12
RO - Romania 12
SA - Arabia Saudita 12
HN - Honduras 11
PT - Portogallo 10
DK - Danimarca 9
GR - Grecia 9
JO - Giordania 9
KE - Kenya 9
PH - Filippine 9
NZ - Nuova Zelanda 7
SN - Senegal 7
TN - Tunisia 7
UY - Uruguay 7
AZ - Azerbaigian 6
LB - Libano 6
PY - Paraguay 6
AO - Angola 5
BO - Bolivia 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
DZ - Algeria 4
ET - Etiopia 4
GY - Guiana 4
HU - Ungheria 4
KZ - Kazakistan 4
SI - Slovenia 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
AL - Albania 3
GT - Guatemala 3
KG - Kirghizistan 3
NO - Norvegia 3
NP - Nepal 3
PS - Palestinian Territory 3
SM - San Marino 3
AM - Armenia 2
BY - Bielorussia 2
CY - Cipro 2
OM - Oman 2
PA - Panama 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
BG - Bulgaria 1
BH - Bahrain 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BS - Bahamas 1
Totale 31.219
Città #
Singapore 2.167
San Jose 1.513
Jacksonville 1.495
Chandler 1.333
Dublin 1.121
Ashburn 738
Southend 690
Council Bluffs 637
Princeton 567
Dallas 511
Beijing 500
Izmir 454
Nanjing 444
Los Angeles 340
Wilmington 299
Dearborn 260
Cambridge 241
Santa Clara 234
Ho Chi Minh City 221
Tongling 183
Altamura 162
The Dalles 162
New York 159
Buffalo 151
Nanchang 148
Hanoi 140
Chieti 128
Munich 116
Ann Arbor 114
Woodbridge 109
Rome 105
Moscow 101
Hong Kong 95
Boardman 93
Milan 91
São Paulo 91
Shenyang 84
Hebei 76
Orem 71
Redondo Beach 71
Tianjin 71
Houston 68
Jiaxing 61
Grevenbroich 53
Hefei 52
Helsinki 51
Kunming 49
Pescara 49
Toronto 48
Washington 47
London 45
Tokyo 43
Brooklyn 41
Norwalk 41
Warsaw 40
Atlanta 39
Chennai 39
Hangzhou 38
Changsha 37
Columbus 36
Montreal 36
Jinan 34
Denver 33
Da Nang 30
Frankfurt am Main 29
Stockholm 29
Turku 29
Chicago 28
Lanzhou 28
San Francisco 28
Haiphong 27
Manchester 26
Naples 26
Florence 25
Rio de Janeiro 25
Belo Horizonte 24
Phoenix 24
Mexico City 23
Poplar 23
Augusta 21
Biên Hòa 21
Dong Ket 21
Johannesburg 21
Seoul 20
Changchun 19
Orange 19
Ardabil 18
Boston 18
Charlotte 18
Falls Church 18
Ningbo 18
Taizhou 18
Amsterdam 17
Nuremberg 17
Paris 17
Baghdad 16
Brno 16
Dudelange 16
Mumbai 16
Tashkent 16
Totale 18.071
Nome #
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 1.224
Emergenza neurologica - tempesta distonica: diagnosi e terapia 501
EDONISMO OMEOSTATICO, COMPLICAZIONE RARA DELLA MALATTIA DI PARKINSON: 10 ANNI DI FOLLOW-UP. 316
La Mattis Dementia Rating Scale e la NPI messi al confronto nella valutazione della malattia di Alzheimer, demenza a corpi di Lewy diffusa e la malattia di Parkinson con Demenza, in una popolazione del centro Italia. 289
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 203
Pre-trattamento antiematico per Test/terapia all'apomorfina 201
Dropped head syndrome with necrotizing myopathy: A drug class effect confirmed by 3 repeated exposures to non ergolinic dopamine agonists, due to L-Dopa phobia 191
The Characterization of Regulatory T-Cell Profiles in Alzheimer’s Disease and Multiple Sclerosis 187
Le anomalie EEG precoci predicono la comparsa di fluttuazionicognitive nella con demenza. 181
Akinetic crisis in Dementia with Lewy Bodies 172
NUOVI MARKER DIAGNOSTICI NELLA DEMENZA A CORPI DI LEWY. 170
Amygdala-vmPFC dysfunction as a marker of dementia in parkinsonism 169
Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies 169
Ascertainment bias in dementias: a secondary to tertiary centre analysis in Central Italy and conceptual review 165
Specializzazione funzionale della corteccia visiva nell'uomo. Studio con risonanza magnetica funzionale e potenziali evocati visivi 163
TREMORE PSEUDO - ORTOSTATICO RESPONSIVO ALLA LEVO - DOPA IN PARKINSONISMO. 161
Amyloid B-1-42 stimulated T cells express protein kinase C-delta and/or protein kinase C-Z in Alzheimer disease. 160
Structural alteration of the dorsal visual network in DLB patients with visual hallucinations: a cortical thickness MRI study 160
Brainstem Midline Assessed by Transcranial Sonography in Parkinson's Disease: Further Evidence of a Different Etiopathogenesis of Alexithymia and Depression 160
Amyloid-specific T-cells differentiate Alzheimer's disease from Lewy body dementia 159
Diagnosi differenziale tra malattia da prioni e possibile variante di demenza fronto-temporale: un caso clinico 159
Updates on Somatoform Disorders (SFMD) in Parkinson's Disease and Dementia with Lewy Bodies and discussion of phenomenology. 157
L’EEG nel Mild Cognitive Impairment (MCI): valore predittivo per lo sviluppo di demenza a corpi di Lewy. 157
Fisiopatologia dei ritardi di conduzione nella sclerosi multipla 155
Functional specialization in human visual cortex: Evaluation by visual evoked potentials and fMRI 154
A Critical Review of Alien Limb-Related Phenomena and Implications for Functional Magnetic Resonance Imaging Studies 154
Progetto atrofia multisistemica: risultati preliminari. 152
COMBINED REHABILITATION PROGRAM FOR POSTURAL INSTABILITY IN PROGRESSIVE SUPRANUCLEAR PALSY 152
Improving diagnostic accuracy of DLB: An MRI study 152
Amantadine and antiglutamatergic drugs in the management of Parkinson’s disease 152
Thalamic Involvement in Fluctuating Cognition in Dementia with Lewy Bodies: Magnetic Resonance Evidences. 151
Bipallidal lesions induce delayed and progressive parkinsonism 150
Long half-life and prolonged-release receptor agonists:a review of ropinirole prolonged- release studies. 149
EEG comparison in early AD, LBD, PDD patients with a 2 years follow-up. 147
Default mode network links to visual hallucinations: A comparison between Parkinson's disease and multiple system atrophy 146
Attention network in AD and DLB patients: a resting fMRI study. 145
Diagnosis and treatment of late-onset myoclonic epilepsy in Down syndrome (LOMEDS): A systematic review with individual patients' data analysis 144
Tolcapone vs entacapone: efficacia ed effetti collaterali nel trattamento della sindrome di Parkinson 144
Autoscopic phenomena: case report and review of literature. 144
Amantadine for dyskinesia in patients affected by severe Parkinson's disease. 142
A stage-based approach to therapy in parkinson’s disease 142
Structural connectivity is differently altered in dementia with Lewy body and Alzheimer’s disease 141
Eyelid retraction in dementia with Lewy Bodies and Parkinson’s Disease 140
Amygdala-vmPFC dysfunction as a marker of dementia in parkinsonism. 139
Acute akinesia or akinetic crisis in Parkinson's disease. 137
Persistent genital arousal disorder associated with functional hyperconnectivity of an epileptic focus. 137
Echo long time STIR sequence magnetic resonance imaging of optic nerves in optic neuritis 135
Cortical Activation During Levitation and Tentacular Movements of Corticobasal Syndrome 135
Manifestazioni ossessivo-compulsive nella Malattia di Parkinson. 134
Effects of dexpramipexole on brain mitochondrial conductances and cellular bioenergetic efficiency 133
Cohort study on Somatoform Disorders in Parkinson’s Disease and Dementia with Lewy Bodies 132
Catamenial end-off dose in Parkinson's disease 132
Acute akinesia in Parkinson disease. 132
3D localization of interictal epileptic activity by neuromagnetic method 131
Donepezil vs vitamina E nella malattia di Alzheimer (AD): confronto tra P300 Event Related Potential e Test Neuropsicologici. 131
Heat shock protein 70: implication for Alzheimer's disease 131
Delayed blink reflex in dementia with Lewy bodies is sensitive to cholinergic modulation. 131
Morphological and Metabolic Changes in the Nigro-Striatal Pathway of Synthetic Proteasome Inhibitor (PSI)-Treated Rats: A MRI and MRS Study. 131
Camptocormia nella Malattia di Parkinson e nella demenza a corpi di Lewy 131
Cortical rhythms in ad, LBD and normal subjects: A quantitative meg study 131
Olanzapina: il nuovo trattamento della Sindrome di Gilles de La Tourette 130
Atrofia Multisistemica: approccio diagnostico multidisciplinare 130
Pathological Gambling in PD is reduced by Amantadine 129
P3 topography in brain lesions 128
Reasons driving treatment modification in Parkinson's disease: Results from the cross-sectional phase of the REASON study 128
Neurite ottica: relazione tra perimetria, PEV e RMN 127
Valutazione dei potenziali evocativi visivi durante terapia con farmaci antipsicotici atipici in pazienti con schizofrenia 127
Adherence to anti-Parkinson drug therapy in the "rEASON" sample of Italian patients with Parkinson's disease: The linguistic validation of the Italian version of the "morisky Medical Adherence scale-8 items" 127
Extra-hippocampal alteration of grey matter in dementia with Lewy bodies and Alzheimer’s disease 126
Mitochondrial Involvement in Neurodegenerative Dementia 126
Altitudinal visual stimuli and the cruciform model of evoked potentials. 125
Camptocormia in Lewy Body disease (LBD) in comparison with Parkinson’s Disease (PD) 125
Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset parkinsonism 125
Are VEP abnormalities in optic neuritis (ON) dependent on plaque size? A reappraisal of the physiopathology of ON based on improved MRI and multiple-lead recordings. 124
AMANTADINE EFFECT ON PARKINSON'S DISEASE IMPULSE CONTROL DISORDER 124
Mixed resting and postural tremor with overflow in orthostatism is observed in PDD/DLB patients 123
Atrophy of hippocampal subfields and adjacent extrahippocampal structures in dementia with Lewy bodies and Alzheimer's disease 123
Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions 123
EEG IN PARKINSON'S DISEASE WITH DEMENTIA PREDICTS THE APPEARANCE OF FLUCTUATING COGNITION. XL Congresso SIN, Padova, novembre 2009. 122
Extra-hippocampal alteration of grey matter in dementia with Lewy bodies and Alzheimer’s disease 122
L’ecografia transcranica nello studio del parenchima cerebrale: la nostra casistica 121
The predictive power of transcranial sonography in movement disorders: a longitudinal cohort study 121
TRATTAMENTO CON TOSSINA BOTULINICA DELLA DISTONIA ASSIALE LATERALE NEL PARKINSONISMO. 120
Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment. 120
Prevalenza dei disturbi motori e non motori nella popolazione di pazienti con demenza a corpi di Lewy afferente al nostro centro per i disordini del movimento e le demenze. 120
Relevance of subcortical visual pathways disruption to visual symptoms in dementia with Lewy bodies. 119
Somatization in Parkinson's Disease: A systematic review 119
Post traumatic stress disorder heralding the onset of semantic frontotemporal dementia 119
Visual Hallucinations in PD and Lewy body dementias: Old and new hypotheses 118
Cohort study on tremor in DLB: prevalence and features 118
Camptocormia in Lewy Body Disease (LBD) in comparison with Parkinson’s Disease (PD). 118
Cortical rhythms in ad, lbd and normal subjects: a quantitative MEG study 118
Registrazioni dei potenziali evocati visivi ed evento_correlati in un paziente affetto da sindrome di Balint 117
Fluctuating cognition and different cognitive and behavioural profiles in Parkinson's disease with dementia: comparison of dementia with Lewy bodies and Alzheimer's disease. 117
ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease 117
Are P300 asymmetries in focal brain lesions reference dependent? 116
Two novel POLG1 mutations in a patient with progressive external ophthalmoplegia, levodopa-responsive pseudo-orthostatic tremor and parkinsonism. 116
Polymorphisms of chemokine receptor genes in Alzheimer's and Parkinson's Patients 116
PSI proteasome inhibitor induced rat model of Parkinson’s Disease. 116
Acetyl-L-carnitine:from a biological curiosity to a drug for the peripheral nervous system and beyond. 116
Totale 15.669
Categoria #
all - tutte 122.444
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.444


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.055 0 25 27 129 60 31 26 95 71 46 175 370
2022/20233.715 301 430 246 390 366 759 240 244 492 55 89 103
2023/20241.714 133 75 124 85 92 432 429 52 37 63 29 163
2024/20254.251 266 717 618 126 103 156 100 241 340 260 437 887
2025/202610.353 840 336 992 1.226 799 630 1.525 621 1.608 801 680 295
2026/2027684 228 456 0 0 0 0 0 0 0 0 0 0
Totale 31.899